Genetic Variation in the HN and SH Genes of Mumps Viruses: A Comparison of Strains from Mumps Cases with and without Neurological Symptoms

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Cui, Aili ^a,b   Brown, David W G ^b   Xu, Wenbo ^a   Jin, Li ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ NEURAMINIDASE PROTEIN; SMALL HYDROPHOBIC PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEMAGGLUTININ NEURAMINIDASE GENE; HUMAN; MUMPS; MUMPS VIRUS; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL HYDROPHOBIC GENE; THROAT CULTURE; TISSUE CULTURE; VIRUS GENE; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; GENOTYPE; HN PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; MUMPS; MUMPS VIRUS; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRULENCE;

ANIMALIA; MUMPS VIRUS;

EID: 84876524045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061791     Document Type: Article

References (48)

1. Hviid A, Rubin S, Muhlemann K, (2008) Mumps. Lancet 371: 932-944.
2. World Health Organization (2012) Mumps virus nomenclature update: 2012. Weekly Epidemiological Record (WER) 87: 217-224.
3. Jin L, Rima B, Brown D, Örvell C, Tecle T, et al. (2005) Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol 150: 1903-1909.
4. Santos CL, Ishida MA, Foster PG, Sallum MA, Benega MA, et al. (2008) Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of Sao Paulo, Brazil. J Med Virol 80: 323-329.
5. Saito H, Takahashi Y, Harata S, Tanaka K, Sano T, et al. (1996) Isolation and characterization of mumps virus strains in a mumps outbreak with a high incidence of aseptic meningitis. Microbiol Immunol 40: 271-275.
6. Sugiura A, Yamada A, (1991) Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 10: 209-213.
7. Tecle T, Johansson B, Jejcic A, Forsgren M, Örvell C, (1998) Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 79 (Pt 12): 2929-2937.
8. Tecle T, Bottiger B, Örvell C, Johansson B, (2001) Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J Gen Virol 82: 2675-2680.
9. Furesz J, Contreras G, (1990) Vaccine-related mumps meningitis-Canada. Can Dis Wkly Rep 16: 253-254.
10. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, et al. (1993) Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet 341: 979-982.
11. Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, et al. (1995) Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 346: 701-702.
12. Rubin SA, Pletnikov M, Taffs R, Snoy PJ, Kobasa D, et al. (2000) Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol 74: 5382-5384.
13. Afzal MA, Yates PJ, Minor PD, (1998) Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis 177: 265-266.
14. Amexis G, Fineschi N, Chumakov K, (2001) Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287: 234-241.
15. Brown EG, Wright KE, (1998) Genetic studies on a mumps vaccine strain associated with meningitis. Rev Med Virol 8: 129-142.
16. Cusi MG, Santini L, Bianchi S, Valassina M, Valensin PE, (1998) Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidasegene in wild-type strains of mumps virus is the most relevant marker of virulence. J Clin Microbiol 36: 3743-3744.
17. Kovamees J, Rydbeck R, Örvell C, Norrby E, (1990) Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 17: 119-129.
18. Mori C, Tooriyama T, Imagawa T, Yamanishi K, (1997) Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain. J Infect Dis 175: 1548-1549.
19. Rafiefard F, Johansson B, Tecle T, Örvell C, (2005) Characterization of mumps virus strains with varying neurovirulence. Scand J Infect Dis 37: 330-337.
20. Rubin SA, Amexis G, Pletnikov M, Li Z, Vanderzanden J, et al. (2003) Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 77: 11616-11624.
21. Tecle T, Mickiene A, Johansson B, Lindquist L, Örvell C, (2002) Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch Virol 147: 243-253.
22. Carbone KM, Rubin S (2007) Mumps Virus; Knipe D HP, Griffin D, Lamb R, Martin M. Lippincott Williams, editor.
23. Crennell S, Takimoto T, Portner A, Taylor G, (2000) Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 7: 1068-1074.
24. Kulkarni-Kale U, Ojha J, Manjari GS, Deobagkar DD, Mallya AD, et al. (2007) Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 359: 436-446.
25. Örvell C, Kalantari M, Johansson B, (1997) Characterization of five conserved genotypes of the mumps virus small hydrophobic (SH) protein gene. J Gen Virol 78 (Pt 1): 91-95.
26. Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, et al. (2001) Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res 74: 133-137.
27. Örvell C, Tecle T, Johansson B, (2002) Mumps virus: an underestimated viral pathogen. Current Topics in Virol 2: 100-113.
28. Jin L, Beard S, Brown DW, (1999) Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis 180: 829-833.
29. Minor PD, Macadam AJ, Stone DM, Almond JW, (1993) Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21: 357-363.
30. Brown EG, Dimock K, Wright KE, (1996) The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis 174: 619-622.
31. Saika S, Kidokoro M, Ohkawa T, Aoki A, Suzuki K, (2002) Pathogenicity of mumps virus in the marmoset. J Med Virol 66: 115-122.
32. Yates PJ, Afzal MA, Minor PD, (1996) Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 77 (Pt 10): 2491-2497.
33. Sauder CJ, Zhang CX, Link MA, Duprex WP, Carbone KM, et al. (2009) Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence. Vaccine 27: 5822-5829.
34. Santos-Lopez G, Scior T, Borraz-Arguello Mdel T, Vallejo-Ruiz V, Herrera-Camacho I, et al. (2009) Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein. Braz J Infect Dis 13: 24-34.
35. Reyes-Leyva J, Banos R, Borraz-Arguello M, Santos-Lopez G, Rosas N, et al. (2007) Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin-neuraminidase glycoprotein. Microbes Infect 9: 234-240.
36. Malik T, Wolbert C, Mauldin J, Sauder C, Carbone KM, et al. (2007) Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. J Gen Virol 88: 2533-2541.
37. Malik TH, Wolbert C, Nerret L, Sauder C, Rubin S, (2009) Single amino acid changes in the mumps virus haemagglutinin-neuraminidase and polymerase proteins are associated with neuroattenuation. J Gen Virol 90: 1741-1747.
38. Arruda WO, Kondageski C, (2001) Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Parana, Brazil, 1998. Rev Inst Med Trop Sao Paulo 43: 301-302.
39. Cizman M, Mozetic M, Radescek-Rakar R, Pleterski-Rigler D, Susec-Michieli M, (1989) Aseptic meningitis after vaccination against measles and mumps. Pediatr Infect Dis J 8: 302-308.
40. Malik T, Shegogue CW, Werner K, Ngo L, Sauder C, et al. (2011) Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence. J Virol 85: 6082-6085.
41. Xu P, Luthra P, Li Z, Fuentes S, D'Andrea JA, et al. (2012) The V protein of mumps virus plays a critical role in pathogenesis. J Virol 86: 1768-1776.
42. Lemon K, Rima BK, McQuaid S, Allen IV, Duprex WP, (2007) The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol 81: 8293-8302.
43. Sauder CJ, Zhang CX, Ngo L, Werner K, Lemon K, et al. (2011) Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol 85: 7059-7069.
44. Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, et al. (2006) Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350: 48-57.
45. Domingo E, Holland JJ, (1997) RNA virus mutations and fitness for survival. Annu Rev Microbiol 51: 151-178.
46. Jin L, Richards A, Brown DW, (1996) Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol Cell Probes 10: 191-200.
47. Jin L, Brown DW, Litton PA, White JM, (2004) Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis 189: 1001-1008.
48. Jin L, Beard S, Hale A, Knowles W, Brown DW, (2000) The genomic sequence of a contemporary wild-type mumps virus strain. Virus Res 70: 75-83.